Online first
Review paper
Published online: 2024-07-01
How to improve patient outcomes following TAVI in 2024? Recent advances
Abstract
Not available
References
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022; 43(7): 561–632.
- Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 143(5): e35–e71.
- Marzec K, Jaworska-Wilczyńska M, Kowalik I, et al. Comparison of long-term outcomes and risk factors of aortic stenosis treatment in patients undergoing transcatheter aortic valve implantation and surgical aortic valve replacement. Kardiol Pol. 2022; 80(7-8): 792–798.
- Forrest JK, Deeb GM, Yakubov SJ, et al. Evolut Low Risk Trial Investigators. 4-year outcomes of patients with aortic stenosis in the Evolut Low Risk Trial. J Am Coll Cardiol. 2023; 82(22): 2163–2165.
- Capodanno D, Petronio AS, Prendergast B, et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2017; 52(3): 408–417.
- Zareian R, Tseng JC, Fraser R, et al. Effect of stent crimping on calcification of transcatheter aortic valves. Interact Cardiovasc Thorac Surg. 2019; 29(1): 64–73.
- Thyregod HG, Jørgensen TH, Ihlemann N, et al. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart J. 2024; 45(13): 1116–1124.
- Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement in low-risk patients at five years. N Engl J Med. 2023; 389(21): 1949–1960.
- Stinis CT, Abbas AE, Teirstein P, et al. Real-world outcomes for the fifth-generation balloon expandable transcatheter heart valve in the United States. JACC Cardiovasc Interv. 2024; 17(8): 1032–1044.
- Yamamoto M, Yashima F, Shirai S, et al. Performance and outcomes of the SAPIEN 3 Ultra RESILIA transcatheter heart valve in the OCEAN-TAVI registry. EuroIntervention. 2024; 20(9): 579–590.
- Sun M, Elkhodiry M, Shi L, et al. A biomimetic multilayered polymeric material designed for heart valve repair and replacement. Biomaterials. 2022; 288: 121756.
- Taghizadeh B, Ghavami L, Derakhshankhah H, et al. Biomaterials in valvular heart diseases. Front Bioeng Biotechnol. 2020; 8: 529244.
- Tang GHL, Zaid S, Kleiman NS, et al. Explant vs redo-TAVR after transcatheter valve failure: Mid-term outcomes from the EXPLANTORREDO-TAVR international registry. JACC Cardiovasc Interv. 2023; 16(8): 927–941.
- Tarantini G, Sathananthan J, Fabris T, et al. Transcatheter aortic valve replacement in failed transcatheter bioprosthetic valves. JACC Cardiovasc Interv. 2022; 15(18): 1777–1793.
- Sá MP, Jacquemyn X, Van den Eynde J, et al. Impact of paravalvular leak on outcomes after transcatheter aortic valve implantation: Meta-analysis of Kaplan-Meier-derived individual patient data. Struct Heart. 2023; 7(2): 100118.
- Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019; 380(18): 1706–1715.
- Carabello BA, Puskas JD. Transcatheter aortic valve replacement. JACC: Cardiovascular Interventions. 2014; 7(9): 1033–1035.
- Jilaihawi H, Kashif M, Fontana G, et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol. 2012; 59(14): 1275–1286.
- Wong DTL, Bertaso AG, Liew GYH, et al. Relationship of aortic annular eccentricity and paravalvular regurgitation post transcatheter aortic valve implantation with CoreValve. J Invasive Cardiol. 2013; 25(4): 190–195.
- Hagar A, Li Y, Wei X, et al. Incidence, predictors, and outcome of paravalvular leak after transcatheter aortic valve implantation. J Interv Cardiol. 2020; 2020: 8249497.
- Ong G, Annabi MS, Clavel MA, et al. Paravalvular regurgitation after transcatheter aortic valve replacement: Is the problem solved? Interv Cardiol Clin. 2018; 7(4): 445–458.
- Patel J, Weissman G, Rogers T, et al. A word of caution regarding postdilatation of self-expanding valves for paravalvular leak. JACC Cardiovasc Interv. 2024; 17(5): 696–698.
- Stundl A, Rademacher MC, Descoups C, et al. Balloon post-dilation and valve-in-valve implantation for the reduction of paravalvular leakage with use of the self-expanding CoreValve prosthesis. EuroIntervention. 2016; 11(10): 1140–1147.
- Wely Mv, Rooijakkers M, Stens N, et al. Paravalvular regurgitation after transcatheter aortic valve replacement: Incidence, quantification, and prognostic impact. Eur Heart J Imaging Methods and Practice. 2024; 2(2): qyae040.
- Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement: JACC State-of-the-Art review. J Am Coll Cardiol. 2019; 74(3): 362–372.
- Faroux L, Campelo-Parada F, Munoz-Garcia E, et al. Procedural characteristics and late outcomes of percutaneous coronary intervention in the workup pre-TAVR. JACC Cardiovasc Interv. 2020; 13(22): 2601–2613.
- Kondoleon NP, Layoun H, Spilias N, et al. Effectiveness of pre-TAVR CTA as a screening tool for significant CAD before TAVR. JACC Cardiovasc Interv. 2023; 16(16): 1990–2000.
- Nai Fovino L, Scotti A, Massussi M, et al. Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after TAVR-in-TAVR. J Am Heart Assoc. 2020; 9(13): e016446.
- Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: Insights from a large multicenter registry. J Am Coll Cardiol. 2013; 62(17): 1552–1562.
- Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Insights from the VIVID registry. Eur Heart J. 2018; 39(8): 687–695.
- Khan JM, Greenbaum AB, Babaliaros VC, et al. The BASILICA trial: Prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interv. 2019; 12(13): 1240–1252.
- Kitamura M, Majunke N, Holzhey D, et al. Systematic use of intentional leaflet laceration to prevent TAVI-induced coronary obstruction: feasibility and early clinical outcomes of the BASILICA technique. EuroIntervention. 2020; 16(8): 682–690.
- Yudi MB, Sharma SK, Tang GHL, et al. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement. J Am Coll Cardiol. 2018; 71(12): 1360–1378.
- Akodad M, Lounes Y, Meier D, et al. Transcatheter heart valve commissural alignment: an updated review. Front Cardiovasc Med. 2023; 10: 1154556.
- Hosseinpour A, Gupta R, Kamalpour J, et al. Balloon-expandable versus self-expanding transcatheter aortic valve implantation in patients with small aortic annulus: A meta-analysis. Am J Cardiol. 2023; 204: 257–267.
- Kim WK, Möllmann H, Walther T, et al. Predictors of permanent pacemaker implantation after ACURATE neo transcatheter heart valve implantation. Pacing Clin Electrophysiol. 2021; 44(2): 410–415.
- Badertscher P, Knecht S, Zeljković I, et al. Management of conduction disorders after transcatheter aortic valve implantation: Results of the EHRA survey. Europace. 2022; 24(7): 1179–1185.
- Pagnesi M, Kim WK, Baggio S, et al. Incidence, predictors, and prognostic impact of new permanent pacemaker implantation after TAVR with self-expanding valves. JACC Cardiovasc Interv. 2023; 16(16): 2004–2017.
- Ciobanu AO, Gherasim L, Vinereanu D. Risk of stroke after transcatheter aortic valve implantation: epidemiology, mechanism, and management. Am J Ther. 2021; 28(5): e560–e572.
- Kapadia SR, Makkar R, Leon M, et al. Cerebral embolic protection during transcatheter aortic-valve replacement. N Engl J Med. 2022; 387(14): 1253–1263.
- Richter I, Abdel-Wahab M, Desch S, et al. Cerebral embolic protection in patients undergoing transcatheter aortic valve implantation: Recent advances. Kardiol Pol. 2022; 80(6): 644–650.
